这垃圾玩意是要退市了_老虎社区_美港股上老虎 - 老虎社区

点赞
评论
收藏

Tiger KING
09-11

这垃圾玩意是要退市了吗？

银诺医药-B：Cowin China Growth Fund II, L.P.减持，好仓比例降至2.48%

Cowin China Growth Fund II, L.P.于2026年9月10日以每股均价3.8185港元卖出银诺医药-B股份399.00万股，涉资约1523.58万港元。Cowin China Growth Fund II, L.P.此次减持前持有银诺医药-B好仓1441.64万股，占比3.43%；减持后持股量为1042.64万股，好仓比例降至2.48%。原文链接：Hong Kong Exchanges and Clearing Limited

银诺医药-B：Cowin China Growth Fund II, L.P.减持，好仓比例降至2.48%

# 港股大股东股权变动纵览

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

点赞

举报

评论

推荐
最新

empty

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":606594827023680,"tweetId":"606594827023680","gmtCreate":1789118030322,"gmtModify":1789118888392,"author":{"id":4208055296387250,"idStr":"4208055296387250","authorId":4208055296387250,"authorIdStr":"4208055296387250","name":"Tiger KING","avatar":"https://static.tigerbbs.com/fd2a34d2512ec1548d6729559f09ae0d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":7,"crmLevelSwitch":1,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":15,"starInvestorFlag":false},"themes":[{"themeId":"904f2fcf6cfd4b1e8ae6945d2e8283cf","categoryId":"2929bb7468f5415f853fd96fb35d7c3b","name":"港股大股东股权变动纵览","type":2,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":904f2fcf6cfd4b1e8ae6945d2e8283cf}&rnconfig={\"headerBarHidden\": true}","description":"港股公司重要股权披露信息汇总，第一时间了解大股东增减持情况。","image":"https://static.tigerbbs.com/6a9e7846a45988a7917fc6e47e39fec6"}],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>这垃圾玩意是要退市了吗？</p></body></html>","htmlText":"<html><head></head><body><p>这垃圾玩意是要退市了吗？</p></body></html>","text":"这垃圾玩意是要退市了吗？","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/606594827023680","repostId":1196120627,"repostType":2,"repost":{"id":"1196120627","kind":"news","weMediaInfo":{"introduction":"追踪最新港股股权披露信息。","home_visible":1,"media_name":"港股披露","id":"1078898823","head_image":"https://community-static.tradeup.com/news/a632f2fd508536f86d1ef761a603574c"},"pubTimestamp":1789117940,"share":"https://www.laohunote.com/m/news/1196120627?lang=zh_CN&edition=full","pubTime":"2026-09-11 17:12","market":"hk","language":"zh","title":"银诺医药-B：Cowin China Growth Fund II, L.P.减持，好仓比例降至2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196120627","media":"港股披露","summary":"Cowin China Growth Fund II, L.P.于2026年9月10日以每股均价3.8185港元卖出银诺医药-B股份399.00万股，涉资约1523.58万港元。Cowin China Growth Fund II, L.P.此次减持前持有银诺医药-B好仓1441.64万股，占比3.43%；减持后持股量为1042.64万股，好仓比例降至2.48%。原文链接：Hong Kong Exchanges and Clearing Limited","content":"<p><p>Cowin China Growth Fund II, L.P.于2026年9月10日以每股均价3.8185港元卖出银诺医药-B股份399.00万股，涉资约1523.58万港元。</p><p>Cowin China Growth Fund II, L.P.此次减持前持有银诺医药-B好仓1441.64万股，占比3.43%；减持后持股量为1042.64万股，好仓比例降至2.48%。</p><p>原文链接：<a href=\"https://sc.hkexnews.hk/TuniS/di.hkex.com.hk/di/NSForm2.aspx?fn=CS20260910E00324&sa2=ns&sid=510987&sd=11/09/2025&ed=11/09/2026&sa1=cl&scsd=11/09/2025&sced=11/09/2026&sc=02591&src=Main&lang=ZH&tk=ds\" target=\"_blank\">Hong Kong Exchanges and Clearing Limited</a></p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>银诺医药-B：Cowin China Growth Fund II, L.P.减持，好仓比例降至2.48%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n银诺医药-B：Cowin China Growth Fund II, L.P.减持，好仓比例降至2.48%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1078898823\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/a632f2fd508536f86d1ef761a603574c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">港股披露 </p>\n<p class=\"h-time\">2026-09-11 17:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>Cowin China Growth Fund II, L.P.于2026年9月10日以每股均价3.8185港元卖出银诺医药-B股份399.00万股，涉资约1523.58万港元。</p><p>Cowin China Growth Fund II, L.P.此次减持前持有银诺医药-B好仓1441.64万股，占比3.43%；减持后持股量为1042.64万股，好仓比例降至2.48%。</p><p>原文链接：<a href=\"https://sc.hkexnews.hk/TuniS/di.hkex.com.hk/di/NSForm2.aspx?fn=CS20260910E00324&sa2=ns&sid=510987&sd=11/09/2025&ed=11/09/2026&sa1=cl&scsd=11/09/2025&sced=11/09/2026&sc=02591&src=Main&lang=ZH&tk=ds\" target=\"_blank\">Hong Kong Exchanges and Clearing Limited</a></p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02591":"银诺医药-B"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196120627","content_text":"Cowin China Growth Fund II, L.P.于2026年9月10日以每股均价3.8185港元卖出银诺医药-B股份399.00万股，涉资约1523.58万港元。Cowin China Growth Fund II, L.P.此次减持前持有银诺医药-B好仓1441.64万股，占比3.43%；减持后持股量为1042.64万股，好仓比例降至2.48%。原文链接：Hong Kong Exchanges and Clearing Limited","news_type":1,"symbols_score_info":{"02591":1}},"isVote":1,"tweetType":1,"viewCount":328,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":23,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}